AI may help predict responses to non-small cell lung cancer systemic therapies
Using standard-of-care computed tomography (CT) scans in patients with advanced non-small cell lung cancer (NSCLC),…
Browsing: non-small cell lung cancer
Researchers identify marker that may predict whether lung cancer likely to spread
Non-small cell lung cancer (NSCLC) is the most commonly diagnosed cancer, and the leading cause…
Blood test can predict clinical response to immunotherapy in metastatic NSCLC
Non-small cell lung cancer (NSCLC) patients with higher measures of tumour mutations that show up…
Combined drug treatment for lung cancer and secondary tumours
In 20 – 40% of patients with cancer, metastasis (the development of secondary tumours) in…
Dynamic transition of the blood-brain barrier in the development of non-small cell lung cancer
Effective drug delivery through the BTB is one of the greatest therapeutic obstacles in treating…
ESMO 2019: Blood test can replace invasive biopsy for more patients with lung cancer
A growing number of patients with advanced lung cancer could soon be offered a blood…
ASCO 2019: The eight biggest stories on anticancer agents
Here is ecancer’s speedy recap on the presentations from the 2019 American Society of Clinical…
ASCO 2019: Use of broader criteria for clinical trial enrolment would double number of eligible patients with lung cancer
A study looking at 10,500 health records of advanced non-small cell lung cancer (aNSCLC) patients…
ASCO 2019: Pembrolizumab increases historic survival rate for certain people with advanced non-small cell lung cancer
Five-year data from the phase Ib KEYNOTE-001 clinical trial show that pembrolizumab was safe and…
Biologists design new molecules to help stall lung cancer
University of Texas at Dallas scientists have demonstrated that the growth rate of the majority…